(Q54462431)

30 May 2018

title

Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer. (English)

1 reference

30 May 2018

author name string

Aydan Celebiler Cavusoglu

1

1 reference

30 May 2018

Yalin Kilic

2

1 reference

30 May 2018

Serdar Saydam

3

1 reference

30 May 2018

Tulay Canda

4

1 reference

30 May 2018

Zuhal Başkan

5

1 reference

30 May 2018

Ali Ibrahim Sevinc

6

1 reference

30 May 2018

Meral Sakizli

7

1 reference

30 May 2018

publication date

1 September 2009

1 reference

30 May 2018

published in

Cancer Science

1 reference

30 May 2018

volume

100

1 reference

30 May 2018

issue

12

1 reference

30 May 2018

page(s)

2341-2345

1 reference

30 May 2018

Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Targeting key steps in metastatic tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

The biology of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Tumor metastasis: a new twist on epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

TIMPs as multifacial proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Morphogenetic roles of classic cadherins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

CD44 is the principal cell surface receptor for hyaluronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

CD44 expression is associated with increased survival in node-negative invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Tissue inhibitors of metalloproteases: regulation and biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Identification of genes for normalization of real-time RT-PCR data in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Significance of biologic aggressiveness and proliferating activity in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

CD44: structure, function, and association with the malignant process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

CD44 attenuates metastatic invasion during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01333.X

10.1111/J.1349-7006.2009.01333.X

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018